Related references
Note: Only part of the references are listed.Cancer genetics and genomics of human FOX family genes
Masuko Katoh et al.
CANCER LETTERS (2013)
Copy Number Defects of G1-Cell Cycle Genes in Neuroblastoma are Frequent and Correlate with High Expression of E2F Target Genes and a Poor Prognosis
Jan J. Molenaar et al.
GENES CHROMOSOMES & CANCER (2012)
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
Jan J. Molenaar et al.
NATURE (2012)
Comparing Statistical Methods for Constructing Large Scale Gene Networks
Jeffrey D. Allen et al.
PLOS ONE (2012)
Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification
Linda J. Valentijn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Sox10 and S100 in the Diagnosis of Soft-tissue Neoplasms
Jason R. Karamchandani et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2012)
A 6-gene signature identifies four molecular subgroups of neuroblastoma
Frida Abel et al.
CANCER CELL INTERNATIONAL (2011)
miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples
Katleen De Preter et al.
CLINICAL CANCER RESEARCH (2011)
Neural Crest Cell Lineage Restricts Skeletal Muscle Progenitor Cell Differentiation through Neuregulinl-ErbB3 Signaling
Andrew Tri Van Ho et al.
DEVELOPMENTAL CELL (2011)
Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature
Katleen De Preter et al.
CLINICAL CANCER RESEARCH (2010)
Chromosomal and MicroRNA Expression Patterns Reveal Biologically Distinct Subgroups of 11q-Neuroblastoma
Patrick G. Buckley et al.
CLINICAL CANCER RESEARCH (2010)
Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
Sara De Brouwer et al.
CLINICAL CANCER RESEARCH (2010)
Accurate prediction of neuroblastoma outcome based on miRNA expression profiles
Johannes H. Schulte et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Prognostic Impact of Gene Expression-Based Classification for Neuroblastoma
Andre Oberthuer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic significance of HER2 expression in neuroblastic tumors
Ewa Izycka-Swieszewska et al.
MODERN PATHOLOGY (2010)
High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
Helena Caren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells
Sandra Acosta et al.
BMC DEVELOPMENTAL BIOLOGY (2009)
Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
Tobias Otto et al.
CANCER CELL (2009)
Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastoma
Isabella Eckerle et al.
CANCER LETTERS (2009)
Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients
Lorena Passoni et al.
CANCER RESEARCH (2009)
Meta-mining of Neuroblastoma and Neuroblast Gene Expression Profiles Reveals Candidate Therapeutic Compounds
Katleen De Preter et al.
CLINICAL CANCER RESEARCH (2009)
The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
Tom Monclair et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
59-gene prognostic signature sub-stratifies high-risk neuroblastoma patients
Joelle Vermeulen et al.
LANCET ONCOLOGY (2009)
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours
Helena Caren et al.
BIOCHEMICAL JOURNAL (2008)
The ERBB3 receptor in cancer and cancer gene therapy
G. Sithanandam et al.
CANCER GENE THERAPY (2008)
The MSX1 homeobox transcription factor is a downstream target of PHOM and activates the Delta-Notch pathway in neuroblastoma
Ingrid Revet et al.
EXPERIMENTAL CELL RESEARCH (2008)
The kinesin KIF1B beta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
Susanne Schlisio et al.
GENES & DEVELOPMENT (2008)
The prognostic value of serum S100B in patients with cutaneous melanoma: A meta-analysis
Simone Mocellin et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
KIF1Bβ functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death
Arasambattu K. Munirajan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas
Tomoyuki Fujita et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
A Sox10 Expression Screen Identifies an Amino Acid Essential for Erbb3 Function
Kristina Buac et al.
PLOS GENETICS (2008)
ArrayCGH-based classification of neuroblastoma into genomic subgroups
Evi Michels et al.
GENES CHROMOSOMES & CANCER (2007)
Paired overexpression of ErbB3 and Sox10 in pilocytic astrocytoma
Steven O. Addo-Yobo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number
Qun Wang et al.
CANCER RESEARCH (2006)
Reverse engineering cellular networks
Adam A. Margolin et al.
NATURE PROTOCOLS (2006)
Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes
Katleen De Preter et al.
GENOME BIOLOGY (2006)
Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor
R Ho et al.
CANCER RESEARCH (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q
L McArdle et al.
CARCINOGENESIS (2004)
Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR
Pascale Levy et al.
MOLECULAR CANCER (2004)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Revision of the international neuroblastoma pathology classification - Confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular
M Peuchmaur et al.
CANCER (2003)
The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation
T Holbro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The transcription factor Sox10 is a key regulator of peripheral glial development
S Britsch et al.
GENES & DEVELOPMENT (2001)
Share Paper
